These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8738775)

  • 1. Effect of the transition from intravenous to oral dosing on cyclosporin-A trough concentrations in liver transplant patients.
    Maboundou CW; Paintaud G; Bresson-Hadni S; Mantion G; Miguet JP; Bechtel PR
    Ther Drug Monit; 1996 Jun; 18(3):310-4. PubMed ID: 8738775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cyclosporine A after intravenous and oral administration in liver transplant patients measured with high-performance liquid chromatography.
    Klompmaker IJ; Wierda JM; Sluiter WJ; Uges DR; Haagsma EB; Verwer R; Slooff MJ
    Ther Drug Monit; 1993 Feb; 15(1):60-4. PubMed ID: 8451783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipients.
    Winkler M; Haller GW; Oldhafer K; Bechstein WO; Maibücher A; Färber L; Ringe B; Neuhaus P; Pichlmayr R
    Transplant Proc; 1997; 29(1-2):544-6. PubMed ID: 9123122
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
    Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
    Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation.
    Pan SH; Lopez RR; Sher LS; Hoffman AL; Podesta LG; Makowka L; Rosenthal P
    Pharmacotherapy; 1996; 16(1):59-65. PubMed ID: 8700793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting cyclosporine A from intravenous to oral administration in hematopoietic stem cell transplant recipients and the role of azole antifungals.
    Atiq F; Hameli E; Broers AEC; Doorduijn JK; Van Gelder T; Andrews LM; Koch BCP; Versmissen J; de Winter BCM
    Eur J Clin Pharmacol; 2018 Jun; 74(6):767-773. PubMed ID: 29500599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
    Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
    Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients.
    Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P
    Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients.
    Dunn SP; Cooney GF; Kulinsky A; Falkenstein K; Pierson A; Elder CA; Meligeni J
    Transplantation; 1995 Dec; 60(12):1438-42. PubMed ID: 8545871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What significance has the C(2) value in the treatment with cyclosporin A?].
    Pham VV; Stichtenoth DO; Frölich JC
    Dtsch Med Wochenschr; 2004 Mar; 129(13):706. PubMed ID: 15026970
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of cyclosporin a in hair samples from liver transplanted patients.
    Müller A; Jungen H; Iwersen-Bergmann S; Sterneck M; Andresen-Streichert H
    Ther Drug Monit; 2013 Aug; 35(4):450-8. PubMed ID: 23783168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NONMEM population pharmacokinetic modeling of orally administered cyclosporine from routine drug monitoring data after heart transplantation.
    Parke J; Charles BG
    Ther Drug Monit; 1998 Jun; 20(3):284-93. PubMed ID: 9631925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K; Kirchner GI; Rupprecht L; Gruber M; Birnbaum DE; Schmid FX; Preuner JG
    Transplant Proc; 2007 Dec; 39(10):3323-8. PubMed ID: 18089380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single dose of ursodiol does not affect cyclosporine absorption in liver transplant patients.
    Maboundou CW; Paintaud G; Vanlemmens C; Magnette J; Bresson-Hadni S; Mantion G; Miguet JP; Bechtel PR
    Eur J Clin Pharmacol; 1996; 50(4):335-7. PubMed ID: 8803529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.
    Baraldo M; Pea F; Poz D; Furlanut M
    Pharmacol Res; 2001 Jun; 43(6):547-51. PubMed ID: 11419964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.